The present invention is directed to nucleic acid molecules encoding attenuated, non-functional virion infectivity factor ( vif ) proteins. The nucleic acid molecules of the invention are inserted into recombinant expression vectors and administered to mammals in order to induce a cellular and humoral immune response to the encoded protein product.